Selective destruction of nigrostriatal dopaminergic neurons does not alter [3H]-ryanodine binding in rat striatum.

Noël, F; Geurts, M; Maloteaux, J M

Noël, F; Geurts, M; Maloteaux, J M.

Affiliation

Noël F; Departamento de Farmacologia Básica e Clínica, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. fnoel@pharma.ufrj.br

Braz J Med Biol Res ; 33(2): 237-40, 2000 Feb.

Article in En | MEDLINE | ID: mdl-10657066

Subject(s)

Corpus Striatum/metabolism; Dopamine/metabolism; Neuroleptic Malignant Syndrome/metabolism; Neurons/metabolism; Ryanodine Receptor Calcium Release Channel/metabolism; Adrenergic Agents/pharmacology; Animals; Bromocriptine/therapeutic use; Corpus Striatum/drug effects; Dopamine Agonists/therapeutic use; Male; Neuroleptic Malignant Syndrome/drug therapy; Neurons/drug effects; Oxidopamine/pharmacology; Piperazines/metabolism; Rats; Rats, Wistar; Substantia Nigra/drug effects; Substantia Nigra/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dopamine / Ryanodine Receptor Calcium Release Channel / Corpus Striatum / Neuroleptic Malignant Syndrome / Neurons Limits: Animals Language: En Journal: Braz J Med Biol Res Year: 2000 Document type: Article Affiliation country: Brazil Country of publication: Brazil

Search on Google

Add to My VHL

XML

PubMed Links